A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis
PHASE2
This was a phase 2 study to evaluate the safety and efficacy of elsubrutini...
A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State
PHASE2
Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated...
Status
Completed
Location
Duplicate_AZ Arthritis and Rheumotology Research, PLLC /ID# 227833
A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
PHASE2
The main objective of this study was to evaluate the safety and efficacy of...